Writing away the worry: new study tests expressive writing for cancer survivors

NCT ID NCT04776941

Recruiting now Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests whether expressive writing—reading and writing about positive experiences—can help cancer survivors manage stress. About 414 survivors will participate from home using a computer or smartphone. The goal is to see if this simple activity can lower stress and improve quality of life during tough times like the COVID-19 pandemic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: expressive writing (reading and writing about positive experiences)
What this could lead to: If it works, this could offer a simple, at-home way for cancer survivors to reduce stress and improve quality of life.
What could go wrong: This is an early feasibility study, not a large-scale trial. It may not show clear benefits, and results may not apply to all cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.